Blog

June 15, 2022 Brielle Gregory Collins, ASCO staff
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More
June 14, 2022 Elizabeth H. Dibble, MD; Stephanie L. Graff, MD, FACP; Theresa A. Graves, MD, FACS; and Chelsea J. Miller, MD
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer. Read More
June 9, 2022 H. Jack West, MD
Dr. H. Jack West shares what people with lung cancer should know about biomarker testing, including why it is important in planning treatment and what to expect during the testing process. Read More
2022 ASCO Annual Meeting; #ASCO22
June 7, 2022 Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing. Read More
2022 ASCO Annual Meeting; #ASCO22
June 7, 2022 Brielle Gregory Collins, ASCO staff
La reunión anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) tendrá lugar del 3 al 7 de junio y estas son algunas de las investigaciones destacadas que se presentarán. La investigación de hoy incluye un estudio que evalúa si la radioterapia puede evitarse después de la cirugía en personas de 55 años o más con cáncer de mama luminal A de grado bajo, según se identifica mediante el análisis de biomarcadores. Read More

Pages